diatrizoate meglumine has been researched along with Glioblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fadul, CE; Lukovits, TG; Pipas, JM; Williamson, PD | 1 |
| Berenstein, A; Butler, AR; Kricheff, II; Passalaqua, AM | 1 |
2 other study(ies) available for diatrizoate meglumine and Glioblastoma
| Article | Year |
|---|---|
Nonconvulsive status epilepticus after intravenous contrast medium administration.
Topics: Brain Neoplasms; Contrast Media; Diatrizoate Meglumine; Electroencephalography; Glioblastoma; Humans; Injections, Intravenous; Lorazepam; Male; Middle Aged; Phenytoin; Status Epilepticus; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Contrast enhanced CT scan and radionuclide brain scan in supratentorial gliomas.
Topics: Adolescent; Adult; Aged; Astrocytoma; Cerebellar Neoplasms; Child; Child, Preschool; Contrast Media; Diatrizoate Meglumine; Dura Mater; Evaluation Studies as Topic; Female; Glioblastoma; Humans; Male; Meningeal Neoplasms; Middle Aged; Radionuclide Imaging; Tomography, X-Ray Computed | 1979 |